Skip to main content
CStone Pharmaceuticals logo

CStone Pharmaceuticals — Investor Relations & Filings

Ticker · 2616 ISIN · KYG2588M1006 LEI · 300300095A57F80T2461 HKEX Manufacturing
Open in API
Filings indexed 3,374 across all filing types
Latest filing 2020-11-03 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 2616

About CStone Pharmaceuticals

http://www.cstonepharma.com

CStone Pharmaceuticals is an innovation-driven biopharmaceutical company focused on the research, development, and commercialization of anti-tumor drugs. The company is dedicated to addressing the unmet medical needs of cancer patients globally. Its core therapeutic focus is on innovative immuno-oncology and molecularly targeted therapies. The R&D pipeline is strategically balanced, featuring potential first-in-class or best-in-class assets, including Antibody-Drug Conjugates (ADC) and multi-specific antibodies. CStone has successfully launched four innovative drugs and secured multiple New Drug Application and indication approvals.

Recent filings

Filing Released Lang Actions
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2020
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' and is addressed to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized and issued share capital, share options, warrants, convertibles, and other share-related transactions for the month ended 31/10/2020. The content focuses on share capital changes, share issuance, and confirmations related to securities issued. There is no indication of it being a full financial report, earnings release, or management discussion. It is a regulatory filing reporting monthly share capital movements and confirmations to the exchange. This type of document fits best under 'Regulatory Filings' (RNS) as it is a compliance report to the exchange about share capital changes and related confirmations, not a financial report or announcement of a report.
2020-11-03 English
Monthly Returns
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' and is addressed to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions for the month ended 31/10/2020. The content focuses on share capital changes and related confirmations, without any financial performance data, earnings, management discussion, or audit information. It is a regulatory disclosure about share capital movements rather than a financial report or earnings release. Therefore, it fits best under the category of Share Issue/Capital Change (SHA). The document length is substantial and contains detailed data on share capital changes, supporting this classification with high confidence.
2020-11-02 English
ANNOUNCEMENT ON RECEIVING THE LETTER OF PERFORMANCE COMMITMENT FROM THE CONTROLLING SHAREHOLDER
Regulatory Filings Classification · 95% confidence The document is an announcement from Yanzhou Coal Mining Company Limited regarding the receipt of a Letter of Performance Commitment from its controlling shareholder related to an asset acquisition transaction. It details the commitments on net profit performance and compensation mechanisms tied to the acquisition. The document is an announcement of a corporate event related to a transaction and performance commitments, not a full financial report, audit report, or earnings release. It does not contain financial statements or detailed financial analysis but rather describes the terms of a shareholder commitment related to a transaction. This fits best under the category of a Regulatory Filing (RNS) as it is a general regulatory announcement that does not fit other specific categories such as M&A filings or capital updates, since it is about a performance commitment letter rather than the transaction itself or financing. The document length (6397 characters) and content confirm it is not a brief report publication announcement or a full report. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2020-10-30 English
VOLUNTARY ANNOUNCEMENT - LICENSE AGREEMENT FOR ANTIBODY DRUG CONJUGATE LCB71 WITH LEGOCHEM BIOSCIENCES, INC.
Capital/Financing Update Classification · 95% confidence The document is a voluntary announcement by CStone Pharmaceuticals regarding a license agreement with LegoChem Biosciences for an antibody drug conjugate. It details the terms of the license, payments, and strategic significance of the agreement. The text includes no financial statements, quarterly or annual results, or regulatory certifications. It is not a report but an announcement of a business update related to licensing and partnership. The document length is over 11,000 characters, indicating it is a full announcement rather than a brief notice. This fits the category of Capital/Financing Update (CAP) as it relates to licensing agreements and potential milestone payments, which are financing-related activities. It is not an earnings release, annual report, or regulatory filing. Therefore, the appropriate classification is CAP with high confidence.
2020-10-28 English
DISCLOSEABLE TRANSACTION-CAPITAL INCREASE IN INNER MONGOLIA MINING
Capital/Financing Update Classification · 100% confidence The document is an announcement regarding a capital increase transaction by Yanzhou Coal Mining Company Limited involving Inner Mongolia Mining. It details the terms, pricing, payment, closing, and special arrangements related to the capital increase. The document references the Hong Kong Listing Rules and classifies the transaction as a "discloseable transaction" under Chapter 14 of the Listing Rules. The content is focused on a financing/capital structure update rather than a financial report, earnings release, or regulatory filing. It is not a report publication announcement since it contains substantive transaction details and is not merely announcing the release of a report. Therefore, the document fits best under the category of Capital/Financing Update (CAP).
2020-10-28 English
ARTICLES OF ASSOCIATION OF YANZHOU COAL MINING COMPANY LIMITED
Governance Information Classification · 100% confidence The document is titled 'Articles of Association of Yanzhou Coal Mining Company Limited' and contains detailed chapters outlining the company's organizational structure, shareholder rights, board of directors, financial and accounting systems, and other governance-related provisions. It is a comprehensive legal document that sets out the internal rules and governance framework of the company. There is no indication that this is an annual report, financial statement, or any other type of financial or regulatory filing. Instead, it fits the description of a governance information document, detailing the company's internal rules, board structure, and governance practices as per the filing definition for Governance Information (CGR). The document length (15,000 characters) and content confirm it is the actual articles, not an announcement or summary.
2020-10-28 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.